ORIGINAL RESEARCH
Published on 28 Apr 2025
SuFEx-enabled high-throughput medicinal chemistry for developing potent tamoxifen analogs as Ebola virus entry inhibitors
doi 10.3389/fimmu.2025.1533037
- 1,370 views
- Frontiers in Immunology
- Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- Research Topics
- Next Generation Therapeutic Modality to Cure Autoimmune Diseases
Next Generation Therapeutic Modality to Cure Autoimmune Diseases
8,003
Total downloads
28k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 22 Apr 2025
Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy
doi 10.3389/fimmu.2025.1543581
- 916 views
REVIEW
Published on 07 Apr 2025
Immune mediated inflammatory diseases: moving from targeted biologic therapy, stem cell therapy to targeted cell therapy
doi 10.3389/fimmu.2025.1520063
- 1,841 views
CASE REPORT
Published on 07 Jan 2025
Hematopoietic stem cell transplantation as rescue therapy for refractory autoimmune retinopathy: a case report
doi 10.3389/fimmu.2024.1484798
- 1,357 views
- 2 citations
REVIEW
Published on 20 Dec 2024
A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action
doi 10.3389/fimmu.2024.1494499
- 2,678 views
REVIEW
Published on 04 Dec 2024
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases
doi 10.3389/fimmu.2024.1509956
- 3,143 views
- 1 citation
CASE REPORT
Published on 14 Nov 2024
Case report: Abrocitinib: a potential therapeutic option for lichen amyloidosis associated with atopic dermatitis
doi 10.3389/fimmu.2024.1477664
- 1,045 views
REVIEW
Published on 31 Oct 2024
Therapeutic potential of natural coumarins in autoimmune diseases with underlying mechanisms
doi 10.3389/fimmu.2024.1432846
- 1,361 views
- 2 citations
ORIGINAL RESEARCH
Published on 06 Sep 2024
Novel AHR ligand AGT-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the disease
doi 10.3389/fimmu.2024.1454156
- 2,106 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Aug 2024
IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization
doi 10.3389/fimmu.2024.1452849
- 3,926 views
- 2 citations
BRIEF RESEARCH REPORT
Published on 04 Jun 2024
Beta cells deficient for Renalase counteract autoimmunity by shaping natural killer cell activity
doi 10.3389/fimmu.2024.1403752
- 2,514 views
- 1 citation
